Chemical Compound

(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (4S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (-)-Efavirenz; (S)-4-(2-Cyclopropylethynyl)-6-chloro-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-4-(Cyclopropylethynyl)-6-chloro-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; DMP 266; EFV; Efavirenz; L 743726; Stocrin; Sustiva

Brand: EASY CDMO
SKU: 64139

CAS Registry Number 154598-52-4

返回搜索申请报价

Primary record

(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (4S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (-)-Efavirenz; (S)-4-(2-Cyclopropylethynyl)-6-chloro-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-4-(Cyclopropylethynyl)-6-chloro-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; DMP 266; EFV; Efavirenz; L 743726; Stocrin; Sustiva

库存: 9,805 克
纯度: 98.4 %
CAS: 154598-52-4

化合物标识与属性

CAS: 154598-52-4
PubChem CID: 64139
SMILES: C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
Canonical SMILES: O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1

名称与同义词

efavirenz
Sustiva
Stocrin
154598-52-4
Viraday
Efavirenz teva
(-)-Efavirenz
DMP-266
Efavirenzum
Eravirenz
(S)-Efavirenz
(Rac)-Efavirenz
ent Efavirenz
Efavirenz RS
Strocin (TM)
Sustiva (TM)
Sustiva (TN)
zoxazin-2-one
1ikv
1ikw
Efavirenz, (S)
Atripla (TN)
Stocrin (TN)
Efavirenz & PLGA
efavirenz, (S)-
DMP 266
efavirenz, (S)-isomer
GUANFACINE
Sustiva 600
Efavirenz (Standard)
Efavirenz & IFNL1
Efavirenz & IFNL2
Efavirenz & IFNL3
C14H9ClF3NO2
Efavirenz & IL-29
Efavirenz (JAN/INN)
Efavirenz [INN:BAN]
EFAVIRENZ [INN]
EFAVIRENZ [JAN]
DMP-266; Efavirenz
Efavirenz & IL-28A
Efavirenz & IL-28B
EFAVIRENZ [MI]
EFAVIRENZ [HSDB]
EFAVIRENZ [USAN]
EFV & Interleukin 29
RefChem:590606
Efavirenz [USP:INN:BAN]
EFAVIRENZ [VANDF]
JE6H2O27P8
UNII-JE6H2O27P8
EFV & Interleukin 28A
EFV & Interleukin 28B
EFV & PLGA
DTXSID9046029
D07HVY
EFAVIRENZ [MART.]
Epitope ID:231718
HSDB 7163
AC1L20IX
EFAVIRENZ [USP-RS]
EFAVIRENZ [WHO-DD]
EFAVIRENZ [WHO-IP]
EFV & IFNL1
EFV & IFNL2
EFV & IFNL3
CHEBI:119486
DMP266
XPOQHMRABVBWPR-ZDUSSCGKSA-N
Efavirenz (JAN/USP/INN)
EFV & Interferon lambda-1
EFV & Interferon lambda-2
EFV & Interferon lambda-3
Efavirenz & Interleukin 29
Met-SDF-1.beta. & Efavirenz
MFCD05662344
SCHEMBL37762
DTXCID7026029
EFAVIRENZ [EMA EPAR]
Efavirenz & Interleukin 28A
Efavirenz & Interleukin 28B
Efavirenz Ready Made Solution
MLS000759465
MLS001424087
TELURA COMPONENT EFAVIRENZ
BIDD:GT0383
NSC-742403
Efavirenz - Bio-X trade mark
AMY229
BDBM2483
CHEMBL223228
EFV & IL-28A
EFV & IL-28B
orb1305550
EFAVIRENZ [ORANGE BOOK]
Efavirenz, >=98% (HPLC)
CTK8E9137
Efavirenz & Interferon lambda-1
Efavirenz & Interferon lambda-2
Efavirenz & Interferon lambda-3
EFV & IL-29
GTPL11287
KS-00000ZEH
KS-00002WWM
AOB2950
EFAVIRENZ [USP MONOGRAPH]
J05AG03
L-743726
ATRIPLA COMPONENT EFAVIRENZ
NSC742403
BCPP000245
C14-H9-Cl-F3-N-O2
GLXC-04867
HMS2051J08
HMS2090N16
HMS3393J08
HMS3713M14
EFAVIRENZUM [WHO-IP LATIN]
(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
ALBB-038626
BCP27719
CID64139
EFV
MSK10874
ZINC2020233
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
L-743,726
Tox21_111582
DL-535
EBC-12705
HY-10572R
s4685
AKOS015894951
Efavirenz & Poly-lactide-co-glycolide
Tox21_111582_1
AB21723
ACN-029242
BCP9000636
CB11317
CCG-101011
CS-2154
DB00625
EFAVIRENZ 200MG SCORED TABLETS
FC30275
KS-5380
MK-0831
NC00261
NSC 742403
RL01986
RTX-012332
L 743726
Efavirenz 100 microg/mL in Acetonitrile
NCGC00159337-02
NCGC00159337-04
NCGC00159337-12
NCGC00271713-05
NCGC00271713-08
AC-25006
AK323634
BC164402
BC214923
CJ-31514
CPD000466351
HY-10572
SAM001246667
SC-46515
SMR000466351
SY009682
J727.577C
LS-173464
(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
B1119
CAS-154598-52-4
E0997
NS00000604
(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one
C08088
D00896
EN300-219935
F17329
L 741211
L-741211
L-743725
AB00639956-06
AB00639956-08
(-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE
(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
(Rac)-DMP 266; (Rac)-EFV; (Rac)-L-743726
(S)-6-CHLORO-4-(CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE
598E524
A809555
L741211
L743726
Q422645
SR-01000759360
A1200834
SR-01000759360-4
SR-01000759360-5
BRD-K40758068-001-08-2
L 743,726
Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz
177530-93-7
Z2177953192
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-
6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
Efavirenz, United States Pharmacopeia (USP) Reference Standard
EFZ
(4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(s)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one
(S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
Efavirenz solution, 1.0 mg/mL in acetonitrile, certified reference material
(4S)-6-chloranyl-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben
(S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo(d)(1,3)oxazin-2-one
2H-3, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-
2h-3,1-benzoxazin-2-ona, 6-cloro-4-(2-ciclopropiletinil)-1,4-dihidro-4-(trifluorometil)-
6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-3-one
6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(4S)-4-(Cyclopropylethynyl)-4-(trifluoromethyl)-6-chloro-1,4-dihydro-2H-3,1-benzoxazin-2-one
(4S)-4alpha-(Trifluoromethyl)-4-(cyclopropylethynyl)-6-chloro-1,2-dihydro-4H-3,1-benzoxazin-2-one
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (4S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (-)-Efavirenz; (S)-4-(2-Cyclopropylethynyl)-6-chloro-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-4-(Cyclopropylethynyl)-6-chloro-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; DMP 266; EFV; Efavirenz; L 743726; Stocrin; Sustiva
(4S)-6-Chloro-4alpha-(trifluoromethyl)-4-(cyclopropylethynyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-(cyclopropyl-ethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazine-2-one
(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-ben zoxazin-2-one
(S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
2h-3,1-benzoxazin-2-ona, 6-cloro-4-(2-ciclopropiletinil)-1,4-dihidro-4-(trifluorometil)-, (4s)-
2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-
2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-(9
6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo(d)(1,3)oxazin-2-one